Abstract:ABSTRACT Increasing evidence suggests that mutations in the nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may enhance viral replication by modulating the assembly process. However, the mechanisms governing the selective packaging of viral genomic RNA by the N protein, along with the assembly and budding processes, remain poorly understood. Utilizing a virus-like particles (VLPs) system, we have identified that the C-terminal domain (CTD) of the N protein is essential for its interaction with the membrane (M) protein during budding, crucial for binding and packaging genomic RNA. Notably, the isolated CTD lacks M protein interaction capacity and budding ability. Yet, upon fusion with the N-terminal domain (NTD) or the linker region (LKR), the resulting NTD/CTD and LKR/CTD acquire RNA-dependent interactions with the M protein and acquire budding capabilities. Furthermore, the presence of the C-tail is vital for efficient genomic RNA encapsidation by the N protein, possibly regulated by interactions with the M protein. Remarkably, the NTD of the N protein appears dispensable for virus particle assembly, offering the virus adaptive advantages. The emergence of N* (NΔN209) in the SARS-CoV-2 B.1.1 lineage corroborates our findings and hints at the potential evolution of a more streamlined N protein by the SARS-CoV-2 virus to facilitate the assembly process. Comparable observations have been noted with the N proteins of SARS-CoV and HCoV-OC43 viruses. In essence, these findings propose that β-coronaviruses may augment their replication by fine-tuning the assembly process. IMPORTANCE As a highly transmissible zoonotic virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve. Adaptive mutations in the nucleocapsid (N) protein highlight the critical role of N protein-based assembly in the virus’s replication and evolutionary dynamics. However, the precise molecular mechanisms of N protein-mediated viral assembly remain inadequately understood. Our study elucidates the intricate interactions between the N protein, membrane (M) protein, and genomic RNA, revealing a C-terminal domain (CTD)-based assembly mechanism common among β-coronaviruses. The appearance of the N* variant within the SARS-CoV-2 B.1.1 lineage supports our conclusion that the N-terminal domain (NTD) of the N protein is not essential for viral assembly. This work not only enhances our understanding of coronavirus assembly mechanisms but also provides new insights for developing antiviral drugs targeting these conserved processes.

The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release

Structure of SARS-CoV-2 membrane protein essential for virus assembly

Synthesis, insertion, and characterization of SARS-CoV-2 membrane protein within lipid bilayers

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

Direct lipid interactions control SARS-CoV-2 M protein conformational dynamics and virus assembly

Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation

SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains

Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection

Biophysical Modeling of SARS-CoV-2 Assembly: Genome Condensation and Budding

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein

Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core.

Endomembrane remodeling in SARS-CoV-2 infection

ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication

ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress

Correction To: The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation

Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly.

Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b

Membrane Condensation and Curvature Induced by SARS-CoV-2 Envelope Protein

Modular Characterization of SARS-CoV-2 Nucleocapsid Protein Domain Functions in Nucleocapsid-Like Assembly

Study of fusion peptide release for the spike protein of SARS-CoV-2

Bis(Monoacylglycero)Phosphate Promotes Membrane Fusion Facilitated by the SARS-CoV-2 Fusion Domain